tm logo
X CHIOME
Live/Registered
SECTION 71 ACCEPTED

on 06 Feb 2023

Last Applicant/ Owned by

Shibuya-ku,

Tokyo

JP

151-0071

Serial Number

79169641 filed on 28th Apr 2015

Registration Number

5126156 registered on 24th Jan 2017

in the Principal Register

Correspondent Address

Jeffrey H. Handelsman

Jeffrey H. Handelsman

1950 Roland Clarke Place

Reston, VA 20191-1411

Filing Basis

1. filing basis filed as 66 a

Disclaimer

NO DATA

X CHIOME

Research, product development and quality control services in the field of proteins, antibodies, microorganisms and cells, and consultancy relating thereto; research and development services in the field of antibody technology; biomedical research services; [ design and development of medical technology; research and development in the field of biotechnology; ] pharmaceutical research and developm Read More

Classification Information


Class [042]
Computer & Software Services & Scientific Services


Research, product development and quality control services in the field of proteins, antibodies, microorganisms and cells, and consultancy relating thereto; research and development services in the field of antibody technology; biomedical research services; [ design and development of medical technology; research and development in the field of biotechnology; ] pharmaceutical research and development [ ; conducting clinical trials for others in the field of pharmaceutical products; clinical trials for others; technical project studies in the field of monoclonal antibodies for medical or veterinary purposes and pharmaceutical products; technical research in the field of monoclonal antibodies for medical or veterinary purposes and pharmaceutical products; technical project planning in the field of monoclonal antibodies for medical or veterinary purposes and pharmaceutical products; research and development of new products for others; design and development of computer software for use with medical technology; software design and development; providing temporary use of non-downloadable business software; rental of computer software; cloud computing featuring software used for development of monoclonal antibodies for medical or veterinary purposes and pharmaceutical products ]

Class [005]
Pharmaceutical Products


Monoclonal antibodies for medical [ or veterinary ] purposes, namely, for oncological, viral, infectious, endocrine, metabolic, neurological, cardiovascular, hematological, cardiopulmonary, respiratory, musculoskeletal, renal, hepatological, gastrointestinal, genitourinary, ophthalmic, dermatological, and immune system related diseases and disorders; peptides and proteins for medical [ or veterinary ] purposes, namely, for oncological, viral, infectious, endocrine, metabolic, neurological, cardiovascular, hematological, cardiopulmonary, respiratory, musculoskeletal, renal, hepatological, gastrointestinal, genitourinary, ophthalmic, dermatological, and immune system related diseases and disorders; [ biological and chemical preparations and reagents for medical or veterinary purposes, namely, for oncological, viral, infectious, endocrine, metabolic, neurological, cardiovascular, hematological, cardiopulmonary, respiratory, musculoskeletal, renal, hepatological, gastrointestinal, genitourinary, ophthalmic, dermatological, and immune system related diseases and disorders; ] medicines for human purposes, namely, for oncological, viral, infectious, endocrine, metabolic, neurological, cardiovascular, hematological, cardiopulmonary, respiratory, musculoskeletal, renal, hepatological, gastrointestinal, genitourinary, ophthalmic, dermatological, and immune system related diseases and disorders [ ; medicines for dental purposes, namely, for infectious diseases, neurological diseases or inflammatory diseases; medicines for veterinary purposes, namely, for oncological, viral, infectious, endocrine, metabolic, neurological, cardiovascular, hematological, cardiopulmonary, respiratory, musculoskeletal, renal, hepatological, gastrointestinal, genitourinary, ophthalmic, dermatological, and immune system related diseases and disorders; medicinal preparations, namely, for oncological, viral, infectious, endocrine, metabolic, neurological, cardiovascular, hematological, cardiopulmonary, respiratory, musculoskeletal, renal, hepatological, gastrointestinal, genitourinary, ophthalmic, dermatological, and immune system related diseases and disorders; living cells for manufacturing monoclonal antibodies used for medical purposes; cell lines for manufacturing monoclonal antibodies used for medical purposes; living cells for manufacturing monoclonal antibodies used for veterinary purposes; cell lines for manufacturing monoclonal antibodies used for veterinary purposes; biological tissue cultures for medical purposes, namely, for cultivating living cells or cell lines used for manufacturing monoclonal antibodies; dietary supplements for humans; nutritional supplements; dietary supplements for animals; dietetic foods, namely, protein adapted for medical purposes; dietetic beverages, namely, protein-based ready to drink beverages adapted for medical purposes; food for babies; powdered milk for babies; lacteal flour for babies; surgical implants comprised of living tissues; biological implants, namely, a vital processed human or animal connective tissue; disinfectants for hygiene purposes; sanitary sterilising preparations; biocides; preparations for destroying vermin ]

Specimens


X CHIOME specimen

Mark Details


Serial Number

No 79169641

Mark Type

No Service Mark

Attorney Docket Number

No T66872

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

Yes

66A Current

Yes

Current Basis

No

No Basis

No

Design Code(s)

26.11.21 -

Rectangles that are completely or partially shaded

Legal History


Show more

Status DateAction Taken
12th Nov 2023PARTIAL INVALIDATION PROCESSED BY THE IB
11th Oct 2023INVALIDATION PROCESSED
11th Oct 2023PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
06th Oct 2023PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
06th Feb 2023REGISTERED-SEC.71 ACCEPTED
06th Feb 2023NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
03rd Feb 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
29th Jan 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
19th Jan 2023TEAS SECTION 71 RECEIVED
24th Jan 2022COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED